One of the challenges facing the management of skeletal-related events (SREs) is determining the correct antiresorptive therapy and setting for women with breast cancer. Varying data and controversy exist concerning the use of calcium, vitamin D, and bisphosphonates.
To view more videos from this discussion, visit [ Ссылка ]
